Dallas Fort Worth Injury Lawyer Blog

As a Texas medical doctor and Dallas defective drug injury and death attorney, I am providing this update for patients who have been injured by the use of the new Pradaxa anticoagulant drug. According to experts, some Pradaxa patients are exposed to deadly bleeding and stroke risks because Pradaxa has no antidote to reverse its side effects and may cause bleed-out deaths. Many injured patients have filed a Pradaxa lawsuit against Boehringer Ingelheim, the manufacturer of Pradaxa.

Federal Multidistrict Litigation

All federal lawsuits over Pradaxa in U.S. District Courts have been consolidated for pretrial proceedings before U.S. District Judge Herndon in the Southern District of Illinois. Judge Herndon has established 4 bellwether cases for early trial dates, which are expected to go to trial between August 2014 and February 2015. Bellwether trial cases may also help the parties to a settlement agreement.

Countless women take birth control pills and use other hormone containing contraceptive devices world wide every single day, but few realize and understand the deadly risks associated with the medications. Female hormonal contraception can lead to blood clots, a condition known as venous thromboembolism (VTE).

When a blood clot forms inside a deep vein, it is known as deep vein thrombosis (DVT), this kind of blood clot can cause catastrophic health injuries. According to the American Thrombosis Association, approximately 2 million people are affected by DVT each year and around 74 percent of Americans are unaware of the disease.

Our Dallas, Texas based law firm are filing lawsuits against the manufacturers of Nuvaring and Yaz, Yasmin and Ocella birth control medications for the failure to adequately warn women of the potential risks of side effects. The complaints involves similar allegations that drospirenone and the active ingredient in Nuvaring increases the risk of blood clot when compared to some older oral birth control pills. Furthermore, that the manufacturers failed to adequately warn about the risk of users suffering a pulmonary embolism, deep vein thrombosis, stroke or other injury.

As a Dallas Personal Injury and Product Liability Attorney, we are providing this timely news regarding the alleged uterus perforation injuries from the use of a commonly prescribed birth control device known as an Intra Uterine Device (IUD), the Mirena IUD.

Bayer, the manufacturer of Mirena IUD, pushed to centralize its product liability and personal injury lawsuits into New Jersey State Court. The lawsuits are brought by women who experienced serious and often debilitating injuries from the implanted birth control device. Upon review the Supreme Court of New Jersey has decided not to consolidate all Mirena IUD lawsuits.

Now each case filed throughout New Jersey will continue to be litigated individually. Bayer Healthcare filed a request to centralize the New Jersey Mirena litigation in its home state, the company headquarters.

As a Dallas Personal Injury and Product Liability Attorney, we are providing this timely news regarding the alleged Fresenius Granuflo and Naturalyte serious and catastrophic injuries during dialysis. Fresenius Medical Care has agreed to multidistrict litigation (MDL) consolidation for all federal NaturaLyte and Granuflo lawsuits. The injured plaintiffs allege that the dialysis products manufactured, distributed and used by Fresenius Medical Care during dialysis caused patients to suffer a cardiac arrest, heart attack or sudden death.

Many injured kidney failure patients have filed claims against Fresenius Granuflo and Naturalyte, alleging that the company failed to provide warnings to doctors about the importance of monitoring bicarbonate levels among patients during dialysis.

What is Fresenius Granuflo and Naturalyte?

DePuy Orthopaedics and its parent, Johnson and Johnson, are facing more than 6,000 personal injury and defective metal on metal hip product claims in U.S. District Court, Northern District of Ohio. These lawsuits involve its metal on metal ASR hip replacement devices.

DePuy ASR Federal and State 2013 Trials

The first trial date in 2013 over the recalled DePuy ASR artificial metal on metal hip devices is scheduled to begin this week in Maryland state court, with a second trial expected to begin later in January in California state court. The first trial in the federal DePuy ASR hip litigation will begin on May 6, 2013 with a second trial set for July 8, 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197).

As a Dallas Product Liability attorney and Bard Recovery and G2 IVC Filter lawyer, I am writing an update and as I wrote previously in my blogs, there are serious and fatal complications of the widely used Bard inferior vena cava (IVC) filters.

Our law firm on behalf of Judy Kay Alexander from Dallas, Texas have filed a defective product liability lawsuit against C.R. Bard over its G2 IVC Filter. Alexander’s lawsuit alleges that C.R. Bard was negligent, failed to warn, produced a defective design and manufacturing, breach of warranty, and negligent misrepresentation. Alexander suffered significant medical expenses, pain, suffering, loss of enjoyment of life, and disability.

The complaint was filed on December 19 in the U.S. District Court for the Northern District of Texas, Dallas Division. Alexander was implanted with a G2 filter on February 20, 2009, the IVC filter device failed and punctured her inferior vena cava vein and she also suffered damage to her right ureter.

As a Dallas, Texas medical doctor and Fresenius GranuFlo and Naturalyte recall and catastrophic injury attorney I am providing this timely update for folks who have been injured by Fresenius GranuFlo and Naturalyte dialysate solutions.

As the number of product liability lawsuits increase significantly against Fresenius Medical Care over the use of GranuFlo and Naturalyte dialysate solutions, a motion has been filed to consolidate the federal litigation for coordinated pretrial proceedings. This is known as Multi District Litigation or MDL and this consolidation is very common in complex drug and medical device lawsuit claims where there is similarity of the claims and injuries.

The consolidation motion was filed with the U.S. Judicial Panel on Multidistrict Litigation on December 12, requesting that all Naturalyte and GranuFlo lawsuits filed in U.S. District Courts to be consolidated in the District of Massachusetts as part of an MDL.